LEO LOEWE, M.D.; SAMUEL CANDEL, M.D., F.A.C.P.; HAROLD B. EIBER, M.D.
This content is PDF only. Please click on the PDF icon to access.
Despite the uniformly favorable results following the use of antibiotics in the therapy of subacute bacterial endocarditis due to Streptococcus viridans,1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 the same treatment programs when the enterococcus (Streptococcus fecalis) is the offending organism have mostly met with failure. Although an occasional success has been reported,19, 20, 21, 22 the therapy of enterococcus endocarditis still remains a challenge.
The purpose of this communication is to analyze the factors responsible for the failures and to describe methods which have been adopted in an effort
LOEWE L, CANDEL S, EIBER HB. THERAPY OF SUBACUTE ENTEROCOCCUS (STREPTOCOCCUS FECALIS) ENDOCARDITIS*. Ann Intern Med. 1951;34:717–736. doi: https://doi.org/10.7326/0003-4819-34-3-717
Download citation file:
Published: Ann Intern Med. 1951;34(3):717-736.
Cardiology, Endocarditis, Infectious Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use